Top Disposable Incontinence Products Companies

Disposable Incontinence Products Market size was valued at USD 13.33 Billion in 2023 and is poised to grow from USD 14.33 Billion in 2024 to USD 25.55 Billion by 2032, growing at a CAGR of 7.50% during the forecast period (2025-2032).

The market players in the global Disposable Incontinence Products market are witnessing significant competition due to the presence of both large global players and regional companies. There are large number of startups and small regional players entering the market as the barriers for new entrants are not that strict. Major players are expected to engage in a higher degree of mergers and acquisitions to maintain the market edge. 'Procter & Gamble Co. (US) ', 'Essity AB (Sweden) ', 'Unicharm Corporation (Japan) ', 'Cardinal Health, Inc. (US) ', 'Medtronic plc (Ireland) ', 'Coloplast Ltd. (Denmark) ', 'Unicharm Corporation (Japan) ', 'Paul Hartmann AG (Germany) ', 'First Quality Enterprises (US) ', 'CIVCO Medical Solutions (US) ', 'Pigeon Corporation (Japan) ', 'Edgewell Personal Care Company (US) ', 'Hygieia Healthcare (India) ', 'Invacare Corporation (US) ', 'Smartsorb Technologies (US) ', 'Hartmann USA (US) ', 'Karex Berhad (Malaysia) ', 'Seni (Torpol, Poland) ', 'Apex Medical Corp. (Wellell) (Taiwan) ', 'Proven Healthcare (US)'

Rise in Chronic Disease Prevalence

Ease of Availability: Growing awareness of incontinent medical conditions, widespread usage and growing competition among companies has increased the ease of availability. Although the disposable incontinence products are category 2 medical equipment, they are widely available not only in over the counter stores but also in department stores.

Europe is dominating the Disposable Incontinence Products market due to affordable healthcare facilities and widespread awareness. Large number of developed European countries such as UK, Germany, and Netherlands offer free medical treatment to its citizens, or the citizens are covered under free government medical insurance. As a result, hospitalization rate among older patients and patients suffering with chronic disease is significantly high resulting in substantial demand for disposable incontinence products in Europe. Disposable incontinence products are considered as medical equipment and in Europe the government regulates the prices of medical supplies and equipment. As a result, disposable incontinence products are more affordable to the common citizen.